Astellas Pharma Europe
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- DIFLICIR film-coated tablet 200 mg
- D07 - Preparados dermatológicos con corticosteroides
- LOCOID cream 0.1%
- LOCOID CRELO cutaneous emulsion 0.1%
- LOCOID cutaneous solution 0.1%
- LOCOID LIPID cream 0.1%
- LOCOID ointment 0.1%
- MILDISON LIPID cream 1%
- D10 - Preparados contra el acné
- ZINERYT cutaneous solution 4%+1.2%
- D11 - Otros preparados dermatológicos
- PROTOPIC ointment 0.03%
- PROTOPIC ointment 0.1%
- G04 - Urológicos
- BETMIGA prolonged-release tablet 25 mg
- BETMIGA prolonged-release tablet 50 mg
- OMNIC OCAS prolonged-release tablet 0.4 mg
- OMNIC prolonged-release capsule, hard 0.4 mg
- VESICARE film-coated tablet 10 mg
- VESICARE film-coated tablet 5 mg
- J02 - Antimicóticos de uso sistémico
- MYCAMINE powder for solution for infusion 100 mg
- MYCAMINE powder for solution for infusion 50 mg
- L01 - Antineoplásicos
- LEVACT powder for solution for infusion 2.5 mg/ml
- L02 - Terapia endocrina
- ELIGARD powder and solvent for solution for injection 22.5 mg
- ELIGARD powder and solvent for solution for injection 45 mg
- ELIGARD powder and solvent for solution for injection 7.5 mg
- XTANDI capsule, soft 40 mg
- L04 - Inmunosupresores
- ADVAGRAF prolonged-release capsule, hard 0.5 mg
- ADVAGRAF prolonged-release capsule, hard 1 mg
- ADVAGRAF prolonged-release capsule, hard 3 mg
- ADVAGRAF prolonged-release capsule, hard 5 mg
- MODIGRAF granules for oral suspension 0.2 mg
- MODIGRAF granules for oral suspension 1 mg
- PROGRAF capsule, hard 0.5 mg
- PROGRAF capsule, hard 1 mg
- PROGRAF capsule, hard 5 mg
- N01 - Anestésicos
- QUTENZA transdermal patch 179 mg